In a study on ovarian carcinoma, RESV was shown to stimulate immunogenic cell death and cause an increase in the number of mature dendritic cells and cytotoxic T cells, while the combinatorial treatment with PD-1 antibody and RESV markedly inhibited tumor growth in vivo [79]. Here, PDCD1 is linked to ovarian carcinoma.